发明名称 ANTIVIRAL THERAPY FOR HEPATITIS B
摘要 A method is disclosed for the treatment of hepadnavirus infection in animals. Animals infected with duck hepatitis B virus may be treated with the 2 min ,3 min -dideoxynucleoside of adenine, guanine, hypoxanthine, 2,6-diaminopurine or various analogs of substituted purines. Several purine 2 min ,3 min -dideoxynucleosides inhibit duck hepatitis B virus in hepatocyte culture >99% at 1 mu g/ml. Potent in vivo efficacy of the 2,6-diaminopurine 2 min ,3 min -dideoxynucleoside for clearance of duck hepatitis B virus from the sera of Pekin ducks is demonstrated. The selective effect on hepadnavirus replication by the purine 2 min ,3 min -dideoxynucleosides is based on the discovery of an unexpected sensitivity of hepadnavirus to purine 2 min ,3 min -dideoxynucleoside analogs. These compounds present a new antiviral therapy of acute or persistent hepadnavirus infections.
申请公布号 AU2050288(A) 申请公布日期 1989.02.09
申请号 AU19880020502 申请日期 1988.08.08
申请人 THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 发明人 NAME NOT GIVEN
分类号 C07D473/16;A61K;A61K31/52;A61K31/522;A61K31/70;A61P31/12;C07D473/18;C07D473/24;C07D473/30;C07D473/32;C07D473/34;C07D473/40 主分类号 C07D473/16
代理机构 代理人
主权项
地址